OptimizeRx Corp — Director's Dealing 2021

Mar 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2021-03-24

Reporting Person: FEBBO WILLIAM J (Director, CHIEF EXECUTIVE OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-24	Common Stock	S	20000	$50.50	Disposed	273278	Direct
2021-03-25	Common Stock	S	80000	$46.10	Disposed	193278	Direct
2021-03-25	Common Stock	M	394739	$3.21	Acquired	588017	Direct
2021-03-25	Common Stock	F	26710	$47.44	Disposed	561307	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-25	Stock Option	$3.21	M	394739	Disposed	2021-05-21	Common Stock (394739)	Direct

Footnotes

F1: The transactions reported in the above Table 1 Rows 3 and 4 reflect the cashless exercise of a soon to expire stock option. The cashless exercise of the option is reported in two lines. The first line of the cashless exercise transaction is coded M in Column 3 of Table 1 and reports in Column 4 the number of shares issuable upon exercise of the option had cash been paid to exercise the option, together with the exercise price with code A for acquired. The line coded F in Column 3 of Table I relates to the same cashless exercise on the preceding line and reports in Column 4 the number of shares deducted from the total number of shares issuable to pay for the cashless exercise of such options with code D for disposal. The price in Column D reflects the closing price on the date of the cashless exercise. The number of shares on a net basis is actually owned by the Reporting Person after the cashless exercise. The transactions reported in Table II above reflect the disposition of the same stock option whose cashless exercise is disclosed in Table I above. The sales reflected in Table 1, Rows 1 and 2, were sales to generate funds to pay the taxes associated with the cashless exercise.